Cargando…
The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma
Basal cell carcinoma (BCC) is an increasingly common cancer. For high‐risk BCCs, there are several treatment options, with similar efficacies. The current best practice in deciding upon a particular treatment is for a patient‐centred approach. At present, there are few resources available for patien...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804260/ https://www.ncbi.nlm.nih.gov/pubmed/35799319 http://dx.doi.org/10.1111/ced.15325 |
_version_ | 1784862066648023040 |
---|---|
author | Banks, Jamie Odili, Joy Zaidi, Shane Lalondrelle, Susan Singh, Masha Akhras, Victoria Jiyad, Zainab |
author_facet | Banks, Jamie Odili, Joy Zaidi, Shane Lalondrelle, Susan Singh, Masha Akhras, Victoria Jiyad, Zainab |
author_sort | Banks, Jamie |
collection | PubMed |
description | Basal cell carcinoma (BCC) is an increasingly common cancer. For high‐risk BCCs, there are several treatment options, with similar efficacies. The current best practice in deciding upon a particular treatment is for a patient‐centred approach. At present, there are few resources available for patients to assist their choice. This reduces patient autonomy and increases the burden on clinicians within clinic. Patient decision aids (PDAs) have been shown to increase patient autonomy and facilitate shared decision‐making. Currently, there is no published PDA designed to facilitate the decision between surgical management or radiotherapy in high‐risk BCCs. We developed a novel decision aid designed along the International Patient Decision Aid Standards to fill this clinical need, and evaluated its acceptance by both patients and clinicians. We describe the challenges faced at initial alpha and subsequent beta testing, and go on to validate our PDA with both the Decisional Conflict Scale and the nine‐item Shared Decision Making Questionnaire (SDMQ9). We include an example of the PDA and encourage other units to modify the PDA for their own use. |
format | Online Article Text |
id | pubmed-9804260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98042602023-01-03 The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma Banks, Jamie Odili, Joy Zaidi, Shane Lalondrelle, Susan Singh, Masha Akhras, Victoria Jiyad, Zainab Clin Exp Dermatol Concise Reports Basal cell carcinoma (BCC) is an increasingly common cancer. For high‐risk BCCs, there are several treatment options, with similar efficacies. The current best practice in deciding upon a particular treatment is for a patient‐centred approach. At present, there are few resources available for patients to assist their choice. This reduces patient autonomy and increases the burden on clinicians within clinic. Patient decision aids (PDAs) have been shown to increase patient autonomy and facilitate shared decision‐making. Currently, there is no published PDA designed to facilitate the decision between surgical management or radiotherapy in high‐risk BCCs. We developed a novel decision aid designed along the International Patient Decision Aid Standards to fill this clinical need, and evaluated its acceptance by both patients and clinicians. We describe the challenges faced at initial alpha and subsequent beta testing, and go on to validate our PDA with both the Decisional Conflict Scale and the nine‐item Shared Decision Making Questionnaire (SDMQ9). We include an example of the PDA and encourage other units to modify the PDA for their own use. John Wiley and Sons Inc. 2022-08-12 2022-11 /pmc/articles/PMC9804260/ /pubmed/35799319 http://dx.doi.org/10.1111/ced.15325 Text en © 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Concise Reports Banks, Jamie Odili, Joy Zaidi, Shane Lalondrelle, Susan Singh, Masha Akhras, Victoria Jiyad, Zainab The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma |
title | The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma |
title_full | The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma |
title_fullStr | The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma |
title_full_unstemmed | The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma |
title_short | The development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma |
title_sort | development and validation of a decision aid to facilitate patient choice of surgery versus radiotherapy for high‐risk basal cell carcinoma |
topic | Concise Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804260/ https://www.ncbi.nlm.nih.gov/pubmed/35799319 http://dx.doi.org/10.1111/ced.15325 |
work_keys_str_mv | AT banksjamie thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT odilijoy thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT zaidishane thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT lalondrellesusan thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT singhmasha thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT akhrasvictoria thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT jiyadzainab thedevelopmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT banksjamie developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT odilijoy developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT zaidishane developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT lalondrellesusan developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT singhmasha developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT akhrasvictoria developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma AT jiyadzainab developmentandvalidationofadecisionaidtofacilitatepatientchoiceofsurgeryversusradiotherapyforhighriskbasalcellcarcinoma |